Coronavirus (Covid-19) and the vaccine: We asked a doctor about vaccines for those with autoimmune conditions

Filed Under: Costs, Patients

Coronavirus (Covid-19) and the vaccine: We asked a doctor about vaccines for those with autoimmune conditions

“Some of our neighbors living with autoimmune conditions have recently asked us whether it’s safe for them to get their Covid-19 vaccine,” Katherine Tam writes for Epicenter-NYC. “In particular, our neighbors have concerns that due to the nature of the drugs being used to treat autoimmune conditions, those treatments’ effects may conflict with the effectiveness of […]

Coronavirus (Covid-19) and the long haul: More than a quarter of patients still symptomatic after 6 months

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and the long haul: More than a quarter of patients still symptomatic after 6 months

“In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months,” Science Daily reports. “Those findings are described this week in the open-access journal PLOS ONE by Milo Puhan and colleagues at the University of […]

Coronavirus (Covid-19) and the long haul: About 11.1 million Americans have long Covid

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and the long haul: About 11.1 million Americans have long Covid

“About 11.1 million Americans are living with long COVID-19, according to new estimates from The American Academy of Physical Medicine and Rehabilitation,” Gabrielle Masson writes over at Beckers Hospital Review. “Long COVID-19, or persistent symptoms up to six months after being cleared of the illness, affects around 30 percent of individuals who had Covid-19, according […]

Coronavirus (Covid-19) and the vaccine: People are deciding to get it, after months of refusal. Why?

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and the vaccine: People are deciding to get it, after months of refusal. Why?

Eve Besser, 42, of Dekalb, Ill., decided to get the coronavirus vaccine after months of hesitating. What changed her mind? Her 12-year-old son. Besser, a long Covid patient, was reluctant to get the shot because she had heard that for some long Covid patients, the shot makes their illness worse. (For some, it makes them […]

Coronavirus (Covid-19) and the schools: How the Delta variant invaded an elementary school classroom

Filed Under: Costs, Patients, Regulators

Coronavirus (Covid-19) and the schools: How the Delta variant invaded an elementary school classroom

“An unvaccinated elementary schoolteacher infected with the highly contagious Delta variant spread the virus to half of the students in a classroom, seeding an outbreak that eventually infected 26 people, according to a new report from the Centers for Disease Control and Prevention,” Sabrina Imbler and Emily Anthes write for The New York Times. “The […]

Coronavirus (Covid-19) and the tests: Suddenly, in many places, it’s hard (or costly) to get tested — and the results are slow in coming

Filed Under: Costs, Patients

Coronavirus (Covid-19) and the tests: Suddenly, in many places, it’s hard (or costly) to get tested — and the results are slow in coming

(Updated, Sept. 18) Coronavirus (Covid-19) testing has increasingly become more expensive and slower — or at least less dependably fast — with the surge in infections nationwide. Here are some recent findings from our reporting. We have been following the coronavirus (Covid-19) testing situation since May 2020. Here’s an update as of today, April 25, […]

Coronavirus (Covid-19) and the vaccine: F.D.A. gives full approval to Pfizer vaccine

Filed Under: Costs, Health plans, Patients

Coronavirus (Covid-19) and the vaccine: F.D.A. gives full approval to Pfizer vaccine

The Food and Drug Administration granted full approval of the Pfizer coronavirus vaccine today, according to a press release. “Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine,” the release said. “The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention […]

Coronavirus (Covid-19) and costs: Prevention vs. treatment, by the numbers

Filed Under: Costs, Patients

Coronavirus (Covid-19) and costs: Prevention vs. treatment, by the numbers

Eight months after the first Covid vaccine was rolled out in the United States, debate is raging over how to push hesitant Americans to get the shot to help rein in the pandemic that has cost the country trillions of dollars and over a million lives directly and indirectly. ClearHealthCosts zoomed in on the potential health and financial costs of […]

Coronavirus (Covid-19) and the unvaccinated: You might be hit with expensive medical bills, employer mandates

Filed Under: Costs, Health plans, Patients

Coronavirus (Covid-19) and the unvaccinated: You might be hit with expensive medical bills, employer mandates

“People who choose not to get vaccinated against the coronavirus face greater odds of getting seriously ill and hospitalized –- a decision that could risk not just their health, but their finances as employers mandate vaccination and insurance companies look at ways to pass on the costs of treatment,” Ken Alltucker writes over at USA Today. “More […]

Coronavirus (Covid-19) and the vaccines: The third shot is here, for immunocompromised people. How does it work?

Filed Under: Costs, Health plans, Patients

Coronavirus (Covid-19) and the vaccines: The third shot is here, for immunocompromised people. How does it work?

Third shots of the Covid vaccine are now being broadly recommended for people who are immunocompromised. But like a lot of the rest of the vaccine rollout, the change in policy has been a little rocky. The prospect of a third shot has been discussed for quite some time for immunocompromised people. Scientists noticed that […]